Andy Vick

Andy Vick has worked in the field of toxicology, drug disposition, and PKPD for over 20 years. Andy began their career in 1998 as a Scientist at Biogen, followed by a role as a Principal Scientist at Eli Lilly and Company from 2000 to 2007. In 2007, they joined Millipore as a Scientific Director, and then moved on to Seventh Wave Laboratories LLC in 2009, where they held the position of Executive Vice President and Senior Director of PK, Dynamics & Metabolism. From 2013 to 2016, they worked at WIL Research, first as Vice President of Analytical Services and then as Senior Director of Analytical Services. In 2016, they joined Charles River Laboratories, where they held the roles of Corporate Vice President of Global Strategic Accounts, Corporate Vice President of Safety Assessment Midwest, and Senior Site Director of Ashland OH & Skokie IL. Since 2019, they have been an Adjunct Professor at The Ohio State University's College of Pharmacy, Division of Pharmaceutical Chemistry. In 2022, they joined Attralus as Head of Toxicology, Drug Disposition, and PKPD.

Andy Vick received their Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from The Ohio State University in 1998. Prior to that, they obtained a Bachelor's Degree in Zoology/Animal Biology from The Ohio State University in 1993. Andy also holds a certification in Forensic Toxicology.